Single-cell chromatin profiling reveals relapse-related priming in pediatric acute myeloid leukemia
Life Science Alliance · 2026
DOI: 10.26508/lsa.202603746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2026. Verfasst von Boyu Cui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Technology, Anhui Institute of Medicine, Hefei, China cuiboyu6161@126.com. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Chromatin, Single-Cell Analysis. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 安徽省教育厅 | University Natural Science Research Project of Anhui Province, Tianjin Dexiang Biotechnology Co., Ltd.
Abstract (Originalsprache)
Relapse remains the leading cause of treatment failure and mortality in pediatric acute myeloid leukemia (pAML), yet the early molecular features underlying relapse susceptibility remain poorly understood. Here, we leveraged our previously generated single-cell chromatin accessibility dataset comprising 177,500 cells from 16 diagnostic pAML samples with long-term clinical outcome data, spanning t(8;21), inv(16), and FLT3-ITD subtypes and stratified into relapse (RPS) and non-relapsed (NRPS) cases. We show that RPS patients harbor relapse-associated chromatin accessibility signatures already detectable at diagnosis across multiple molecular subtypes. These patients display heightened innate immune and inflammatory activation and expansion of HSC/MPP-like leukemic progenitors with stem cell-like regulatory features. Motif enrichment analyses identify AP-1 family members, together with RUNX1, SPI1, and ETS factors, as central regulators shaping the relapse-associated epigenetic state. Elevated expression of these regulators predicts inferior survival across independent AML cohorts. Collectively, these findings suggest that early epigenetic priming of innate immune and inflammatory programs is associated with a relapse-prone state and highlight this core transcriptional network as a candidate biomarker framework in pAML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Technology, Anhui Institute of Medicine, Hefei, China cuiboyu6161@126.com.
- Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China.
- Key Laboratory of Hematopoietic Malignancies, Diagnosis and Treatment, Zhejiang, China.
- Department of Medical Technology, Anhui Institute of Medicine, Hefei, China.
- School of Biological and Environmental Engineering, Chaohu University, Hefei, China songyunhong2013@163.com.
ORCID-Profile: Boyu Cui, Yunhong Song
Förderung
- 安徽省教育厅 | University Natural Science Research Project of Anhui Province
- Tianjin Dexiang Biotechnology Co., Ltd
Zitieren
APA
Cui, B., Lei, M., Liu, L., Shu, M., Yu, F., Yang, K., Pan, Y., & Song, Y. (2026). Single-cell chromatin profiling reveals relapse-related priming in pediatric acute myeloid leukemia. Life Science Alliance. https://doi.org/10.26508/lsa.202603746
Vancouver
Cui B, Lei M, Liu L, Shu M, Yu F, Yang K, et al. Single-cell chromatin profiling reveals relapse-related priming in pediatric acute myeloid leukemia. Life Science Alliance. 2026. doi:10.26508/lsa.202603746
BibTeX
@article{Cui2026,
author = {Cui, Boyu and Lei, Minghui and Liu, Liwei and Shu, Mingxin and Yu, Furong and Yang, Kai and Pan, Yin and Song, Yunhong},
title = {Single-cell chromatin profiling reveals relapse-related priming in pediatric acute myeloid leukemia},
journal = {Life Science Alliance},
year = {2026},
doi = {10.26508/lsa.202603746}
}
EUVIMED